This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Parker-Hannifin (PH) Displays Bright Prospects Amid Risks
by Zacks Equity Research
Parker-Hannifin (PH) is likely to benefit from robust backlog level and acquisitions. However, high realignment expenses and the coronavirus outbreak-led market downturn remain concerning.
Honeywell to Increase FFP2 & FFP3 Face Mask Output in Europe
by Zacks Equity Research
Honeywell (HON) to produce 70 million FFP2 and FFP3 face masks at its Newhouse site in Scotland to help contain the coronavirus pandemic.
Berry Global Announces Addition of Meltblown Asset in Berlin
by Zacks Equity Research
Berry Global (BERY) extended its global Meltex meltblown capacity, with the inclusion of an additional asset for the production of high-efficiency filtration media required for face masks.
Rexnord (RXN) Q4 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Rexnord's (RXN) fiscal fourth-quarter earnings improve year over year on the back of sales growth.
MRC Global (MRC) Displays Bright Prospects Despite Risks
by Zacks Equity Research
MRC Global (MRC) is likely to gain from contract wins and projects along with its focus on cash flow generation and cost reduction. Low customer demand, and weak oil & gas industry remain concerning.
Crane (CR) Q1 Earnings and Revenues Miss Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) first-quarter 2020 revenues decline 4.1% year over year on lackluster performance across its segments.
Roper (ROP) Earnings Surpass Estimates in Q1, Decline Y/Y
by Zacks Equity Research
Roper's (ROP) first-quarter 2020 revenues improve 5% year over year on impressive performance across its Application Software, and Network Software & Systems segments.
Colfax (CFX) Surges: Stock Moves 6.1% Higher
by Zacks Equity Research
Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Barnes (B) Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Barnes' (B) first-quarter 2020 revenues decline 12.2% year over year on lackluster performance across its segments.
IDEX (IEX) Q1 Earnings & Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
IDEX's (IEX) first-quarter 2020 revenues decline 4.5% year over year on account of lackluster performance across all of its segments.
Graco (GGG) Lags Q1 Earnings Estimates, Withdraws Sales View
by Zacks Equity Research
Graco's (GGG) first-quarter earnings suffer from weak revenue generation and a decline in margins. It suspends revenue projections for the year due to economic uncertainties.
Carlisle (CSL) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Carlisle's (CSL) first-quarter 2020 revenues decline 3.9% year over year on account of lackluster performance across its CIT, CFT and CBF segments, owing to the coronavirus outbreak.
Dover (DOV) Beats on Q1 Earnings, Suspends 2020 Guidance
by Zacks Equity Research
Dover's (DOV) bottom line improves year over year in Q1, as productivity initiatives and cost-control measures help mitigate the impact of the coronavirus pandemic on its top line.
Emerson (EMR) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Emerson's (EMR) second-quarter fiscal 2020 revenues decline 9% year over year on decreased demand, particularly in March, owing to the coronavirus outbreak.
Roper (ROP) to Benefit From Acquisitions Despite Headwinds
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its network software and medical products businesses, and acquired assets. However, high debt and operating expenses are concerning.
Parker-Hannifin Benefits From Acquisitions Despite Cost Woes
by Zacks Equity Research
Parker-Hannifin (PH) to gain from its acquisitive nature, shareholder-friendly policies, unique Win Strategy and growth investments. Realignment expenses and high debts might impact near-term results.
Berry Global Highlights Measures to Fight Coronavirus Outbreak
by Zacks Equity Research
Berry Global (BERY) highlights some of its initiatives for expanding the production of material required for face masks.
Here's Why You Should Avoid Betting on RBC Bearings (ROLL)
by Zacks Equity Research
RBC Bearings (ROLL) has been suffering from difficult end-market conditions, rising cost of sales and several other issues.
Drab Near-Term Prospects for Industrial Manufacturing Stocks
by Avisekh Bhattacharjee
The Manufacturing - General Industrial industry is facing coronavirus-related issues, job losses & other problems. Technological advancement in manufacturing processes will likely be a growth driver.
General Electric Take Multiple Debt Restructuring Actions
by Zacks Equity Research
General Electric (GE) commences multiple actions to strengthen its financial positions. Proceeds from the BioPharma divestment and new debt offerings have been used for reducing leverage.
Allegion (ALLE) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Allegion (ALLE) withdraws guidance for 2020, owing to uncertainties in the end-markets on the impacts of the coronavirus outbreak.
Enerpac Highlights Business Actions Amid Coronavirus Concern
by Zacks Equity Research
Enerpac (EPAC) highlights several actions to maintain a healthy capital structure amid the coronavirus outbreak.
Roper (ROP) Unit's Pilot Program Joined by MegaCorp Logistics
by Zacks Equity Research
Roper's (ROP) business unit DAT's pilot program enables its participants to evaluate and trial its advanced rate-prediction dataset and tools.
Roper's (ROP) Rate Prediction Tools Selected by Schneider
by Zacks Equity Research
Roper's (ROP) business unit, DAT Solutions' forecasting tools allow users to generate rate predictions based on price momentum, prevailing market conditions and historic data.
Macquarie (MIC) Withdraws Guidance on Coronavirus Concerns
by Zacks Equity Research
Macquarie (MIC) withdraws guidance for 2020 and suspends the quarterly cash dividend on the impacts of the coronavirus outbreak.